This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
Eptifibatide - Indications, Dosage, Side Effects and Precautions — Description, Dosage, Side Effects | PillsCard
OTC
Eptifibatide - Indications, Dosage, Side Effects and Precautions
.75 mg/mL, Injection, solution
INN: EPTIFIBATIDE
Data updated: 2026-04-25
Available in:
🇨🇿🇬🇧🇸🇰
Form
INJECTION, SOLUTION
Dosage
.75 mg/mL
Route
INTRAVENOUS
Storage
—
About This Product
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
Avenacy Inc.
ATC Code
B01AC16
Source
OPENFDA_NDC
This medication is an antithrombotic agent, prescribed for the treatment of patients with acute coronary syndrome (heart condition), and those undergoing percutaneous coronary intervention (angioplasty), and stenting (placing of a cylindrical device within vessels). It prevents platelets in the blood from sticking to each other.
⚠️ Warnings
•Discontinue in case of serious uncontrolled bleeding, or if emergency surgery or thrombolytic (drugs are used in medicine to dissolve blood clots) therapy is required.
Caution should be exercised in patients with liver impairment, platelet counts <100,000 mm3; bleeding in the eye, drugs affecting blood, pregnancy.
Check aPTT [activated partial thromboplastin time or ACT(activated clotting time) prior to sheath removal during angioplasty.
It may lead to severe kidney impairment, inflammation of blood vessels, bleeding in the eye, acute pericardial inflammation ( inflammation of the covering of the heart)or aortic dissection (splitting of the layers of the aorta leading to formation of outpouchings).